GXO CEO: Better robot hands, not Olympic-level humanoids, are what businesses really needAugust 31, 2026
Onkure Therapeutics Releases Q2 2026 Financial Results Markets August 5, 2026 AlphaStreet Newsdesk powered by AlphaStreet Intelligence OKUR|EPS -$0.31|Web Loss $15.3M Onkure Therapeutics Inc (OKUR) reported Q2 2026 primary and diluted…
